Drug Companies and Innovation

In this Forbes article, Charles Hooper discusses the process that drug companies go through in researching, developing, and producing new drugs, and how this process is affected by government policy of both the US government and other governments around the world. In particular, he disputes the notion that drugs are "too expensive," and addresses what he think a President Obama might mean for the pharmaceutical industry.